| 2004N-0408 - Regulatory Site Visit Training Program | |||||||||||||||||||||||
| FDA Comment Number : | EC9 | ||||||||||||||||||||||
| Submitter : | Dr. David Shriver | Date & Time: | 10/19/2004 04:10:13 | ||||||||||||||||||||
| Organization : | LifeCell Corporation | ||||||||||||||||||||||
| Private Industry | |||||||||||||||||||||||
| Category : | |||||||||||||||||||||||
| Issue Areas/Comments | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| LifeCell Corporation, a leader in regenerative medicine, wishes to participate in the Center of Biologics Evaluation and Research site visit program for regulatory review staff.
Please feel free to contact me at the following: David A. Shriver, PH.D. Dir., Regulatory & Clinical Affairs LifeCell Corporation One Millennium Way Branchburg, NJ 08876 Phone 908.947.1117 Fax 908.947.1200 e-mail: dshriver@lifecell.com | |||||||||||||||||||||||